Mid-Florida Cancer Centers ( Site 1611) — Orange City, Florida

Mid-Florida Cancer Centers ( Site 1611) is a clinical research site located in Orange City, Florida, United States 32763.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mid-Florida Cancer Centers ( Site 1611) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Florida Cancer Centers ( Site 1611)?

Mid-Florida Cancer Centers ( Site 1611) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Florida Cancer Centers ( Site 1611) conducted?

Mid-Florida Cancer Centers ( Site 1611) has 1 clinical trials on record. Their work covers Metastatic Non-Small Cell Lung Cancer.

Is Mid-Florida Cancer Centers ( Site 1611) accredited by Crixeo Health?

Mid-Florida Cancer Centers ( Site 1611) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Florida Cancer Centers ( Site 1611)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.